ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

National Cancer Act Of 1971 Commemorated In Symposium Marking Progress, Future Goals

December 13, 1991

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011